{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:54:00Z","timestamp":1792839240635,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jhepr.2021.100280","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T01:25:36Z","timestamp":1616117136000},"page":"100280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B"],"prefix":"10.1016","volume":"3","author":[{"given":"Maria","family":"Buti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Palom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Riveiro-Barciela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Roade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100280_bib1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cgh.2018.09.041","article-title":"Long-term effects of treatment for chronic HBV infection on patient-reported outcomes","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2014.06.034","article-title":"Health related quality of life in people with advanced chronic liver disease","volume":"61","author":"Orr","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib3","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1572-0241.2001.03956.x","article-title":"Health-related quality of life in chronic liver disease: the impact of type and severity of disease","volume":"96","author":"Younossi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100280_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-015-0199-y","article-title":"Natural history of chronic hepatitis B virus infection from infancy to adult life \u2013 the mechanism of inflammation triggering and long-term impacts","volume":"22","author":"Wu","year":"2015","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.jhepr.2021.100280_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","author":"Schramm","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205277","article-title":"Impact of successful treatment with direct acting antiviral agents on health-related quality of life in chronic hepatitis C patients","volume":"13","author":"Juanbeltz","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2021.100280_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0215596","article-title":"Quality of life in patients with chronic hepatitis C infection: severe comorbidities and disease perception matter more than liver-disease stage","volume":"14","author":"Cossais","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2021.100280_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0895-4356(02)00531-0","article-title":"Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark","volume":"56","author":"S\u00f8rensen","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2021.100280_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","article-title":"Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis","volume":"46","author":"Bonkovsky","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2008.07.025","article-title":"Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: association with demographic factors, inflammatory activity, and degree of fibrosis","volume":"49","author":"Teuber","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/apt.13269","article-title":"The journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life","volume":"42","author":"Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100280_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0929-6646(08)60153-9","article-title":"Factors associated with quality of life in chronic hepatitis C patients who received interferon plus ribavirin therapy","volume":"107","author":"Chang","year":"2008","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jhepr.2021.100280_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.510300203","article-title":"Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group","volume":"30","author":"Ware","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100280_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0748-8","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits","volume":"15","author":"Smith-Palmer","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100280_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/liv.13900","article-title":"Viral eradication is required for sustained improvement of\u00a0patient-reported outcomes in patients with hepatitis C","volume":"39","author":"Younossi","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100280_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/liv.14171","article-title":"Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: the impact of hepatitis B and C viral replication","volume":"39","author":"Younossi","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100280_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100280_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"Buti","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2021.100280_bib19","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/0168-8278(90)90183-R","article-title":"Hepatitis delta: the virus and the disease","volume":"11","author":"Rizzetto","year":"1990","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a021576","article-title":"Hepatitis D virus: introduction and epidemiology","volume":"5","author":"Rizzetto","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhepr.2021.100280_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006377","article-title":"Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults","volume":"12","author":"Komas","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jhepr.2021.100280_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2036.2012.04993.x","article-title":"Meta-analysis: antiviral treatment for hepatitis D","volume":"35","author":"Triantos","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100280_bib25","series-title":"Committee for Orphan Medicinal Products (COMP)","first-page":"31","year":"2018"},{"issue":"1 Suppl","key":"10.1016\/j.jhepr.2021.100280_bib26","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","article-title":"The hepatitis delta virus: replication and pathogenesis","volume":"64","author":"Sureau","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A\u00a028-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100280_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/apt.15521","article-title":"Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia","volume":"51","author":"Palom","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100280_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jvh.12895","article-title":"Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection","volume":"25","author":"Ricco","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100280_bib30","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10620-015-4006-0","article-title":"Fatigue in patients with chronic hepatitis B living in North America: results from the hepatitis B research network (HBRN)","volume":"61","author":"Evon","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2021.100280_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2019.09.004","article-title":"Health-related quality of life in patients with compensated and decompensated liver cirrhosis","volume":"70","author":"Labenz","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhepr.2021.100280_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MCG.0000000000001179","article-title":"A\u00a0comprehensive review of patient-reported outcomes in patients with chronic liver diseases","volume":"53","author":"Younossi","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100280_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100280_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jhepr.2021.100280_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"1 Suppl","key":"10.1016\/j.jhepr.2021.100280_bib36","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6 Suppl","key":"10.1016\/j.jhepr.2021.100280_bib38","first-page":"7S","article-title":"Validation of health-related quality of life instruments","volume":"29","author":"Cohen","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100280_bib39","first-page":"1849","article-title":"Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib","volume":"38","author":"Younossi","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhepr.2021.100280_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/apt.14423","article-title":"Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-na\u00efve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3","volume":"47","author":"Younossi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2021.100280_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11136-008-9332-7","article-title":"The factorial structure of the chronic liver disease questionnaire (CLDQ)","volume":"17","author":"Schulz","year":"2008","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.jhepr.2021.100280_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1665-2681(19)31618-7","article-title":"Fatigue and depressive symptoms associated with chronic viral hepatitis patients health-related quality of life (HRQOL)","volume":"9","author":"Karaivazoglou","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib43","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/liv.14115","article-title":"Cytokine balance is restored as patient-reported outcomes improve in\u00a0patients recovering from chronic hepatitis C","volume":"29","author":"de Avila","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100280_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential serum cytokine profiles in patients with chronic hepatitis B, C, and hepatocellular carcinoma","volume":"7","author":"Estevez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100280_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67296-9","article-title":"Impact of chronic HCV treatment on quality of life of patients with metabolic disorders in context of immunological disturbances","volume":"10","author":"Kierepa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100280_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2015.07.035","article-title":"Effects of viral eradication with ledipasvir and sofosbuvir, with or without ribavirin, on measures of fatigue in patients with chronic hepatitis C virus infection","volume":"14","author":"Gerber","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100280_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12889-019-6825-y","article-title":"Does unemployment contribute to poorer health-related\u00a0quality of life among Swedish adults?","volume":"19","author":"Norstr\u00f6m","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhepr.2021.100280_bib48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/ijerph15040722","article-title":"Factors related to unemployment in Europe. A cross-sectional study from the COURAGE survey in Finland, Poland and Spain","volume":"15","author":"Leonardi","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jhepr.2021.100280_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6874-12-41","article-title":"Comparing health-related quality of life of employed women and housewives: a cross sectional study from southeast Iran","volume":"12","author":"Saravi","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jhepr.2021.100280_bib50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/eurpub\/cky276","article-title":"Is quality of life impairment associated with chronic diseases dependent on educational level?","volume":"29","author":"Galenkamp","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jhepr.2021.100280_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0037-1621711","article-title":"Targeting hepatitis D","volume":"38","author":"Rizzetto","year":"2018","journal-title":"Semin Liver Dis"}],"updated-by":[{"DOI":"10.1016\/j.jhepr.2022.100526","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T22:46:01Z","timestamp":1623019561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2589555921000562"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100280","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jhepr.2022.100526","asserted-by":"object"}]},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100280"}}